Page 12 - Laboratory Data News Today

And then, of course, you have the issue that there is often a significant lag of weeks between first becoming unwell and then needing oxygen or ventilation, or even unfortunately succumbing to this disease. so the clinical data are taking time, and its because of the natural history of the infection. we have vaccination and some underlying immunity now, so those sorts of outcomes may even be extended further. therefore, the importance of laboratory and experimentation, i think, is more of an iss...

Some underlying immunity now, so those developments might be extended further. therefore, the importance of the laboratory and experimentation, i think, of the laboratory and experimentation, ithink, it of the laboratory and experimentation, i think, it is more of an issue at the moment because of the gap in clinical data. the downside is that we need to be cautious in over interpreting it. i think, rather, the laboratory data should be used to confirm or reject clinical findings. should be used...

Thats because they either werent vaccinated or they were vaccinated with one dose a long time ago and have waning immunity. >> lets talk about that then. theres -- and as youre saying, theres a lot of data out there. you said its an exaggerated curve. theres a lot of data out there suggesting that omicron is less severe. does that line up with what you are seeing, and what does that mean for, as you said, the unvaccinated, and what does it mean for the vaccinated? >> so weve got two different ki...

But south africa doesnt look like the united states. it only has 6% of the population over 65 and 3/4 who had been infected and it has less than a third vaccinated. so were trying to project against the data that we have, the solid data is on how many cases there would be. where were hopeful is based on laboratory data. its based on t cell studies, so were hopeful that it will be less lethal, less veirulent, we know it will be more transmissible. those are the two things we have to juggle throug...

Werent vaccinated or they were vaccinated with one dose a long time ago and have waning immunity. >> lets talk about that, then, because as youre saying, theres a lot of data out there. you said its an exaggerated curve upward. maybe it will be down as well. theres a lot of data out there suggesting omicron is less severe. does that line up with what you are seeing, and what does that mean for, as you said, the unvaccinated, and what does it mean for the vaccinated? >> so weve got two different ...

Like the united states. it only has 6% of the population over 65. it had three-quarters who had been infected, and it has less than a third vaccinated. so were trying to project against the data that we have. the solid data is on how many cases there would be. where were hopeful is based on laboratory data. its based on t-cell studies. so were hopeful that it will be less lethal, less virulent. we know it will be more transmissible, and those are the two things we have to juggle as we go through...

You can — roll—out, is occurring in red and you can see _ roll—out, is occurring in red and you can see it is going up very rapidly— you can see it is going up very rapidly and accelerating and that will continue to happen over the next _ will continue to happen over the next period of time. next slide, please — next period of time. next slide, please. when i showed the side at the last— please. when i showed the side at the last session people said they wanted _ the last session peo...

To have mild disease. thats not surprising. my suspicion is that there are probably many more cases. we just havent identified them. so as we do, i think we will learn more about whether unvaccinated people who are getting infected, whether theyre also having mild disease. obviously, we all hope it does. my expectation right now is for the unvaccinated, it will be like delta, but for the vaccinated who have breakthroughs,tail do better. >> dr. fauci says based off of tests so far, at least, it l...

Fauci. were discussing the news from pfizer as well as the surge in cases from the u.s. from the delta variant. welcome, thank you for being with us. >> lets begin with your action that this is a preliminary study from pfizer, it still has to be gone over by all of you, but what are you, the scientists here in the u.s., thinking about this? first, its a laboratory data that would project what you might see clinically. so the proof will be what they think, but it projects accurately what you woul...

With the new omicron variant the initial study shows that for people with two doses of the mrna vaccine, the protection against infection -- at least laboratory data, we dont have clinical data yet -- diminishes significantly. however, as people from pfizer pointed out, when you get that third shot boost, it dramatically increases the level of laboratory projected protection. in other words, if you look at the level of antibodies and very likely other immune parameters, that you still stay withi...